Effects of Respiratory Muscle Training on Tongue Muscle Function
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Oct 2, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how respiratory muscle training might improve the strength and endurance of tongue muscles in healthy adults. The researchers believe that by training the muscles we use to breathe, we may also help the muscles of the tongue work better. This study is currently looking for participants aged 18 to 65 who are in good health, meaning they don’t have certain medical conditions like neuromuscular diseases or high blood pressure that could affect the results.
If you decide to participate, you’ll be helping scientists learn more about the connection between breathing and tongue muscle function. Participants will undergo assessments to ensure they meet the eligibility criteria, and those who qualify will engage in specific training exercises. It's important to know that this study is focused on healthy individuals, so if you have any serious health issues, you may not be able to take part. Overall, this research could provide insights that benefit future treatments or therapies related to muscle function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Community ambulant adults between 18 to 65 years old as of testing day; able to understand French or Dutch (depending on the study's site of inclusion); BMI ≥ 18 and ≤ 30 kg/m².
- Exclusion Criteria:
- • Any diagnosed neuromuscular or cardiorespiratory disease; diagnosed psychiatric or psychological disorders which could affect adherence to or comprehension of instructions; diagnosed eating disorders; previous or ongoing head and neck cancer; diagnosed OSA; presenting a high-risk of sleep-disordered breathing indicated by a NoSAS score of 8 or higher 32 or a STOP-Bang score of 3 or higher 33,34; resting heart rate (HR) \> 100 beats per minute (bpm) or \< 50 bpm; resting systolic blood pressure (SBP) \> 140 or \< 90 mmHg, diastolic blood pressure (DBP) \> 90 or \< 50 mmHg; oxygen saturation (SpO2) \< 94% at rest on room air. Individuals with abnormal lung function, i.e., forced expiratory volume in 1 second (FEV1) ≤ 80%, forced vital capacity (FVC) ≤ 80%, and FEV1/FVC ≤ 70%, will also be excluded.
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leuven, , Belgium
Louvain La Neuve, , Belgium
Lausanne, , Switzerland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported